BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31136207)

  • 1. Impact of anti-TNF-alpha therapy on colectomy rate and indications for colectomy in ulcerative colitis: comparison of two patient cohorts from 2005 to 2007 and from 2014 to 2016
    Kolehmainen S; Lepistö A; Färkkilä M
    Scand J Gastroenterol; 2019 Jun; 54(6):707-711. PubMed ID: 31136207
    [No Abstract]   [Full Text] [Related]  

  • 2. Inpatient infliximab is ineffective at preventing colectomy for steroid refractory extensive colitis.
    Andrew RE; Lauria A; Puleo FJ; Berg A; Stewart DB
    J Surg Res; 2017 Nov; 219():18-24. PubMed ID: 29078879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada.
    Moore SE; McGrail KM; Peterson S; Raval MJ; Karimuddin AA; Phang PT; Bressler B; Brown CJ
    Dis Colon Rectum; 2014 Jan; 57(1):83-90. PubMed ID: 24316950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tofacitinib Salvage Therapy for Children Hospitalized for Corticosteroid- and Biologic-Refractory Ulcerative Colitis.
    Constant BD; Baldassano R; Kirsch J; Mitchel EB; Stein R; Albenberg L
    J Pediatr Gastroenterol Nutr; 2022 Dec; 75(6):724-730. PubMed ID: 36122389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience.
    Verstockt B; Claeys C; De Hertogh G; Van Assche G; Wolthuis A; D'Hoore A; Vermeire S; Ferrante M
    United European Gastroenterol J; 2019 Nov; 7(9):1215-1225. PubMed ID: 31700634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Outcomes of Paediatric Patients Admitted With Acute Severe Colitis- A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN.
    Krauthammer A; Tzivinikos C; Assa A; Miele E; Strisciuglio C; Urlep D; Serban ED; Singh A; Winter HS; Russell RK; Hojsak I; Malham M; Navas-López VM; Croft NM; Lee HM; Ledder O; Shamasneh I; Hussey S; Huynh HQ; Wine E; Shah N; Sladek M; de Meij TG; Romano C; Dipasquale V; Lionetti P; Afzal NA; Aloi M; Lee K; Martín-de-Carpi J; Yerushalmy-Feler A; Subramanian S; Weiss B; Shouval DS
    J Crohns Colitis; 2019 Dec; 13(12):1518-1526. PubMed ID: 31120524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review.
    Thorne K; Alrubaiy L; Akbari A; Samuel DG; Morrison-Rees S; Roberts SE
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):369-82. PubMed ID: 26825217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study.
    Ma C; Beilman CL; Huang VW; Fedorak DK; Wong K; Kroeker KI; Dieleman LA; Halloran BP; Fedorak RN
    Can J Gastroenterol Hepatol; 2016; 2016():2079582. PubMed ID: 27478817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy.
    Aloi M; D'Arcangelo G; Capponi M; Nuti F; Vassallo F; Civitelli F; Oliva S; Pagliaro G; Cucchiara S
    Dig Liver Dis; 2015 Jun; 47(6):455-9. PubMed ID: 25733340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study.
    Reich KM; Chang HJ; Rezaie A; Wang H; Goodman KJ; Kaplan GG; Svenson LW; Lees G; Fedorak RN; Kroeker KI
    Aliment Pharmacol Ther; 2014 Sep; 40(6):629-38. PubMed ID: 25039715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does anti-TNF therapy reduce the requirement for surgery in ulcerative colitis? A systematic review.
    Filippi J; Allen PB; Hébuterne X; Peyrin-Biroulet L
    Curr Drug Targets; 2011 Sep; 12(10):1440-7. PubMed ID: 21466486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
    Protic M; Seibold F; Schoepfer A; Radojicic Z; Juillerat P; Bojic D; Mwinyi J; Mottet C; Jojic N; Beglinger C; Vavricka S; Rogler G; Frei P
    J Crohns Colitis; 2014 Nov; 8(11):1427-37. PubMed ID: 24908178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
    Fernández-Salazar L; Muñoz F; Barrio J; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; Fernández N; Sánchez-Ocaña R; Joao D; Santos F
    Scand J Gastroenterol; 2016; 51(2):186-95. PubMed ID: 26200929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study.
    Nasuno M; Miyakawa M; Tanaka H; Motoya S
    Digestion; 2017; 95(1):67-71. PubMed ID: 28052276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. As Infliximab Use for Ulcerative Colitis Has Increased, so Has the Rate of Surgical Resection.
    Kin C; Kate Bundorf M
    J Gastrointest Surg; 2017 Jul; 21(7):1159-1165. PubMed ID: 28484890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab.
    Papamichael K; Rivals-Lerebours O; Billiet T; Vande Casteele N; Gils A; Ferrante M; Van Assche G; Rutgeerts PJ; Mantzaris GJ; Peyrin-Biroulet L; Vermeire S
    J Crohns Colitis; 2016 Sep; 10(9):1015-23. PubMed ID: 27022161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Outcomes of Emergency Admissions With Ulcerative Colitis Between 2007 and 2017 in England.
    King D; Rees J; Mytton J; Harvey P; Thomas T; Cooney R; Patel P; Trudgill N
    J Crohns Colitis; 2020 Jul; 14(6):764-772. PubMed ID: 31714573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency subtotal colectomy rates in relation to anti-TNF therapy in inflammatory bowel disease patients: comparison of retrospective cohorts.
    Sajjadi S; Svensson Neufert R; Ruhr E; Tryggmo S; Marsal J; Buchwald P
    Scand J Gastroenterol; 2023 Jan; 58(1):15-19. PubMed ID: 35917586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.